{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T20:31:01Z","timestamp":1721766661290},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1806-9","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T13:08:26Z","timestamp":1537189706000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acquired thrombotic thrombocytopenia purpura associated with severe ADAMTS13 deficiency in a 3-year-old boy: a case report and review of the literature"],"prefix":"10.1186","volume":"12","author":[{"given":"Hamidah","family":"Alias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woon Lee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah Azima Abdul","family":"Muttlib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Wai","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-Khai","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sie Chong Doris","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiza","family":"Alauddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja Zahratul","family":"Azma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"key":"1806_CR1","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/pbc.24612","volume":"60","author":"JA Reese","year":"2013","unstructured":"Reese JA, Muthurajah DS, Kremer Hovinga JA, Vesely SK, Terrell DR, George JN. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired ADAMTS13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013;60:1676\u201382.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1806_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MOP.0b013e32835e7888","volume":"25","author":"C Loirat","year":"2013","unstructured":"Loirat C, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura in children. Curr Opin Pediatr. 2013;25(2):216\u201324.","journal-title":"Curr Opin Pediatr"},{"issue":"11","key":"1806_CR3","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1016\/S2352-3026(16)30125-9","volume":"3","author":"BS Joly","year":"2016","unstructured":"Joly BS, Stepanian A, Leblanc T, Hajage D, Chambost H, Harambat J, et al. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy. Lancet Haematol. 2016;3(11):e537\u201346.","journal-title":"Lancet Haematol"},{"issue":"6","key":"1806_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1055\/s-2005-925478","volume":"31","author":"EJ Lowe","year":"2005","unstructured":"Lowe EJ, Werner EJ. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents. Semin Thromb Hemost. 2005;31(6):717\u201330.","journal-title":"Semin Thromb Hemost"},{"key":"1806_CR5","volume-title":"Genetic Home References: ADAMTS13 gene, ADAM metallopeptidase with thrombospondin type 1 motif 13","author":"NIH, US National Library of Medicine","year":"2017","unstructured":"NIH, US National Library of Medicine. Genetic Home References: ADAMTS13 gene, ADAM metallopeptidase with thrombospondin type 1 motif 13. Bethesda: Lister Hill National Center for Biomedical Communications, US National Library of Medicine; 2017. https:\/\/ghr.nlm.nih.gov\/gene\/ADAMTS13"},{"issue":"6","key":"1806_CR6","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.pcl.2013.08.007","volume":"60","author":"H Trachtman","year":"2013","unstructured":"Trachtman H. HUS and TTP. Pediatr Clin N Am. 2013;60(6):1513\u201326.","journal-title":"Pediatr Clin N Am"},{"issue":"11","key":"1806_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","volume":"8","author":"M Noris","year":"2012","unstructured":"Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol. 2012;8(11):622\u201333. \n                    https:\/\/doi.org\/10.1038\/nrneph.2012.195\n                    \n                  . Epub 2012 Sept 18","journal-title":"Nat Rev Nephrol"},{"key":"1806_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/2277-9175.223740","volume":"7","author":"N Mostofizadeh","year":"2018","unstructured":"Mostofizadeh N, Arefnia S, Hashemipour M, Dehkordi EH. Thrombotic thrombocytopenic purpura in a child with diabetic ketoacidosis. Adv Biomed Res. 2018;7:33.","journal-title":"Adv Biomed Res"},{"key":"1806_CR9","doi-asserted-by":"publisher","unstructured":"De Leonardis F, Koronica R, Daniele RM, Santoro N. Thrombotic thrombocytopenic purpura in a child treated for acute lymphoblastic leukemia: case report and review of literature. J Pediatr Hematol Oncol. 2017; \n                    https:\/\/doi.org\/10.1097\/MPH.0000000000001050\n                    \n                  . [Epub ahead of print]","DOI":"10.1097\/MPH.0000000000001050"},{"issue":"11","key":"1806_CR10","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/1529-0131(199911)42:11<2346::AID-ANR13>3.0.CO;2-X","volume":"42","author":"HI Brunner","year":"1999","unstructured":"Brunner HI, Freedman M, Silverman ED. Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum. 1999;42(11):2346\u201355.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1806_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard NA, Blanshette VS, Kelton JG, Nair RC, et al. Comparison of plasma exchanges with plasma infusion in the treatment for TTP. Canadian Apheresis Study Group. N Engl J Med. 1991;325(6):393\u20137.","journal-title":"N Engl J Med"},{"issue":"1","key":"1806_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00005792-200301000-00003","volume":"82","author":"P Coppo","year":"2003","unstructured":"Coppo P, Bussel A, Charrier S, Adrie C, Galicier L, Boulanger E, et al. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura\/hemolytic-uremic syndrome. Medicine (Baltimore). 2003;82(1):27\u201338.","journal-title":"Medicine (Baltimore)"},{"key":"1806_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1505533","volume":"374","author":"F Peyvandi","year":"2016","unstructured":"Peyvandi F, Scully M, Hovinga JAK, et al. Caplacizumab for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2016;374:511\u201322.","journal-title":"N Engl J Med"},{"issue":"2","key":"1806_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1586\/17474086.2016.1122515","volume":"9","author":"C Tersteeg","year":"2016","unstructured":"Tersteeg C, Verhenne S, Roose E, et al. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura \u2013 current perspectives and new treatment strategies. Expert Rev Hematol. 2016;9(2):209\u201321.","journal-title":"Expert Rev Hematol"},{"issue":"19","key":"1806_CR15","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood-2017-06-788026","volume":"130","author":"M Scully","year":"2017","unstructured":"Scully M, Kn\u00f6bl P, Kentouche K, et al. Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura. Blood. 2017;130(19):2055\u201363.","journal-title":"Blood"},{"issue":"5","key":"1806_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/bjh.13654","volume":"171","author":"S Hassan","year":"2015","unstructured":"Hassan S, Westwood JP, Ellis D, Laing C, Mc Guckin S, Benjamin S, Scully M. The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP registry. Br J Haematol. 2015;171(5):830\u20135.","journal-title":"Br J Haematol"},{"issue":"2","key":"1806_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3324\/haematol.11739","volume":"93","author":"F Peyvandi","year":"2008","unstructured":"Peyvandi F, Lavoretano S, Palla R, Feys HB, Vanhoorelbeke K, Battagliolo T, et al. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica. 2008;93(2):232\u20139.","journal-title":"Haematologica"},{"issue":"8","key":"1806_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","volume":"115","author":"JA Kremer Hovinga","year":"2010","unstructured":"Kremer Hovinga JA, Vesely SK, Terrell DR, L\u00e4mmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2010;115(8):1500\u201311.","journal-title":"Blood"},{"issue":"8","key":"1806_CR19","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/j.1538-7836.2012.04808.x","volume":"10","author":"G Bettoni","year":"2012","unstructured":"Bettoni G, Palla R, Valsecchi C, Consonni D, Lotta LA, Trisolini SM, et al. ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura. J Thromb Haemost. 2012;10(8):1556\u201365.","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1806-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1806-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T23:17:53Z","timestamp":1568675873000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1806-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1806"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1806-9","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"6 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval from The National University of Malaysia (UKM) Research Ethics Committee is not required for this report submission. The Research Ethics Committee, The National University of Malaysia operates in accordance to the International Conference of Harmonization Good Clinical Practice Guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"276"}}